On September 13, 2022 Abeona Therapeutics Inc. (Nasdaq: ABEO) reported that Vish Seshadri, Chief Executive Officer of Abeona, will participate in a panel discussion at the Cantor Fitzgerald Cell and Genetic Medicines Conference on Thursday, September 15, 2022 (Press release, Abeona Therapeutics, SEP 13, 2022, View Source [SID1234619493]). The panel discussion, entitled, "Late Stage and Commercial Gene & Cell Therapy Warriors: How They Got to/Crossed the Finish Line," is scheduled to begin at 2:30 p.m. ET. The Company will also participate in one-on-one investor meetings at the conference.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Those interested in attending the panel discussion or requesting a one-on-one meeting with Abeona are encouraged to contact their Cantor Fitzgerald representative.